GTAB B
NGM Main Regulated
Biotechnology & Pharmaceuticals
Health Care
Glycorex Transplantation is active in biotechnology. The company conducts research, development and marketing in the field of organ transplantation. The company's main product enables transplants regardless of the blood type of the donor or recipient. Transplantation using the company's product is carried out on a global level. Glycorex Transplantation was founded in 1996 and has its headquarters in Lund.
Read moreInterim report Q3'26
Revenue M
EBIT-% (adj.)
EPS (adj.)
Dividend %
Don't miss out - create an account and get all the possible benefits